CALLISTO PHARMACEUTICALS INC Earnings Per Share (Diluted)
CALLISTO PHARMACEUTICALS INC reported Earnings Per Share (Diluted) of -$0.02 per share for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2012-11-19
- CALLISTO PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2012-09-30 was -$0.02.
- CALLISTO PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2012-06-30 was $0.74.
- CALLISTO PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2012-03-31 was -$0.02.
- CALLISTO PHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2011-12-31 was -$0.01.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$0.02 10-Q · filed 2012-11-19 | $0.71 derived: net income ÷ weighted average shares · filed 2012-11-19 | $0.69 10-Q · filed 2012-11-19 | $0.68 derived: net income ÷ weighted average shares · filed 2012-11-19 |
| 2012-06-30 | $0.74 10-Q/A · filed 2012-08-28 | $0.72 10-Q/A · filed 2012-08-28 | $0.70 derived: net income ÷ weighted average shares · filed 2012-08-28 | $0.70 derived: net income ÷ weighted average shares · filed 2012-11-19 |
| 2012-03-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2012-05-15 | -$0.03 derived: net income ÷ weighted average shares · filed 2012-05-15 | -$0.04 derived: net income ÷ weighted average shares · filed 2012-11-19 | -$0.05 derived: net income ÷ weighted average shares · filed 2012-11-19 |
| 2011-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2012-03-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2012-11-19 | -$0.03 derived: net income ÷ weighted average shares · filed 2012-11-19 | -$0.04 derived: net income ÷ weighted average shares · filed 2012-03-30 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-19 | -$0.02 derived: net income ÷ weighted average shares · filed 2012-11-19 | -$0.03 10-Q · filed 2012-11-19 | -$0.06 derived: net income ÷ weighted average shares · filed 2012-11-19 |
| 2011-06-30 | -$0.02 10-Q/A · filed 2012-08-28 | -$0.03 10-Q/A · filed 2012-08-28 | -$0.06 derived: net income ÷ weighted average shares · filed 2012-08-28 | -$0.08 derived: net income ÷ weighted average shares · filed 2012-08-28 |
| 2011-03-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2012-05-15 | -$0.04 derived: net income ÷ weighted average shares · filed 2012-05-15 | -$0.07 derived: net income ÷ weighted average shares · filed 2012-05-15 | -$0.10 derived: net income ÷ weighted average shares · filed 2012-05-15 |
| 2010-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2012-03-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2012-03-30 | -$0.10 derived: net income ÷ weighted average shares · filed 2012-03-30 | -$0.37 derived: net income ÷ weighted average shares · filed 2012-03-30 |
| 2010-09-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2011-11-14 | -$0.06 derived: net income ÷ weighted average shares · filed 2011-11-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2011-11-14 | |
| 2010-06-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2011-08-15 | -$0.37 derived: net income ÷ weighted average shares · filed 2011-08-15 | ||
| 2009-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2012-03-30 |